Oncotarget

PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signaling.

Leukopenia, weight loss and oral mucositis induced by 5-Fluorouracil in hamsters' model: A regenerative approach using electrospun poly(Lactic-co-Glycolic Acid) membrane

5-氟尿嘧啶在仓鼠模型中引起的白细胞减少、体重减轻和口腔黏膜炎：一种利用电纺聚（乳酸-乙醇酸）膜的再生方法

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and STAT3 signaling regardless of KRAS or BRAF mutational status

瑞戈非尼与 TAS102 协同作用，对抗多种胃肠道癌症，并克服癌症干细胞、三氟尿苷诱导的血管生成、ERK1/2 和 STAT3 信号传导，无论 KRAS 或 BRAF 突变状态如何

Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy

组蛋白去乙酰化酶和聚 ADP 核糖聚合酶抑制剂与地西他滨对胰腺癌细胞的协同细胞毒性：对新疗法的启示

Inhibition of miR-10b treats metastatic breast cancer by targeting stem cell-like properties

抑制 miR-10b 通过靶向干细胞样特性治疗转移性乳腺癌

Integrated stress response (ISR) activation and apoptosis through HRI kinase by PG3 and other p53 pathway-restoring cancer therapeutics

PG3 和其他 p53 通路修复癌症疗法通过 HRI 激酶激活综合应激反应 (ISR) 并导致细胞凋亡

GZ17-6.02 interacts with proteasome inhibitors to kill multiple myeloma cells

GZ17-6.02 与蛋白酶体抑制剂相互作用杀死多发性骨髓瘤细胞

GZ17-6.02 kills PDX isolates of uveal melanoma

GZ17-6.02 可杀死葡萄膜黑色素瘤 PDX 分离株

ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells

ABT199/venetoclax 与噻替哌的协同作用增强了氟达拉滨、克拉屈滨和白消安在 AML 细胞中的细胞毒性

Relationship between the expressions of DLL3, ASC1, TTF-1 and Ki-67: First steps of precision medicine at SCLC

DLL3、ASC1、TTF-1 和 Ki-67 表达之间的关系：SCLC 精准医疗的第一步